23rd, 24th and 25th January 2025
Welcome
After the success of the first editions, the X Liquid Biopsy Symposium has arrived, with the same desire to offer and share the most recent knowledge about the different possibilities of liquid biopsy. As done before, we will approach the topic from interesting perspectives such as clinical utility, progress made in biological knowledge and the continuous technological advances, all of it in a scenario of training, discussion and addressing future challenges.
As organiser of the Symposium, I would like to introduce you to the scientific programme, bringing together a group of prominent experts who will lead a range of sessions and talks, during which we will address specific aspects of liquid biopsy and the different oncological pathologies.
The Symposium is aimed primarily at oncologists (both specialists and residents), biologists, pathologists and research staff. It also a great training opportunity for the pharmaceutical industry given the global nature of its contents.
Therefore, we hope you will enjoy the event and will regard it as a source of professional enrichment on the road to precision oncology.
Scientific coordinator

Dr. Rafael López
Medical Oncology Service
Complejo Hospitalario Universitario de Santiago (CHUS)

NETWORKING EVENT IN DOWNTOWN
THURSDAY, JANUARY 25th 2024
20:15 - 22:00 PM
Sala Riquela
Rua Preguntoiro, 35
Santiago de Compostela
Presentations 2024 - SE HAN BORRADO LOS PDFS
BIENVENIDA /
WELCOME
REUNIÓN CON EXPERTOS: IMPLANTACIÓN DE BIOMARCADORES EN CLÍNICA /
MEETING WITH EXPERTS: BIOMARKER IMPLEMENTATION INTO THE CLINICS
AVANZANDO EN TECNOLOGÍAS Y APLICACIONES DE LA BIOPSIA LÍQUIDA /
ADVANCING IN TECHNOLOGIES AND APPLICATIONS OF LIQUID BIOPSY
Dr. Marta Toledano, Instituto Maimónides de Investigación Biomédica, Córdoba
Dr. Iñaki Comino-Méndez, Instituto de Investigación Biomédica de Málaga (IBIMA)
INNOVACIÓN EN EL CONTEXTO DE LOS TESTS NO INVASIVOS /
INNOVATION IN THE CONTEXT OF NON-INVASIVE TESTS
Eva Colás, CSO & Co-Founder in MIMARK, Barcelona.
Martin Kräter, Chief Scientific Officer in Rivercyte, Erlangen, Germany.
Alessio Marcozzi, Director R&D in Cyclomics, Utrech, The Netherlands.
Yanira Heredia, CEO in Altum Sequencing, Madrid.
CÓMO AVANZAR EN LA ESTANDARIZACIÓN Y ACREDITACIÓN DE TEST
DE BIOPSIA LÍQUIDA /
HOW TO PROGRESS TO THE STANDARDIZATION AND
CERTIFICATION OF LIQUID BIOPSY TESTS
Dr. Evi Lianidou, University of Athens, Greece
Raquel García Navarro, Jefa de Servicio del Área de Control de Mercado de productos para diagnóstico in vitro, AEMPS, Madrid
ESTADO ACTUAL DE LA BIOPSIA LÍQUIDA EN LA CLÍNICA /
CURRENT STATUS OF LIQUID BIOPSY IN THE CLINICS
Dr. Javier Pascual López, Instituto de Investigación Biomédica de Málaga (IBIMA)
BIOPSIA LÍQUIDA PARA EL MANEJO CLÍNICO DEL CÁNCER DE PULMÓN /
LIQUID BIOPSY APPROACHES FOR THE CLINICAL MANAGEMENT OF LUNG CANCER
Dr. Miguel A. Molina-Vila, Hospital Universitario Dexeus, Barcelona
Dr. Miguel García-Pardo, Hospital Universitario Ramón y Cajal, Madrid
MESA REDONDA SOBRE EL ACCESO A PRUEBAS DE BIOPSIA LÍQUIDA /
PANEL DISCUSSION ON THE ACCESS TO LIQUID BIOPSY ANALYSES
INMUNOBIOPSIA LÍQUIDA /
IMMUNE LIQUID BIOPSY
Dr. Ana Dávila, Complexo Hospitalario Universitario de Santiago de Compostela
Dr. Enrique Sanz García, Princess Margaret Cancer Centre, Toronto, Canada
DISEMINACIÓN, EVOLUCIÓN CLONAL Y HETEROGENEIDAD TUMORAL /
TUMOUR DISSEMINATION, CLONAL EVOLUTION AND HETEROGENEITY
Dr. Fara Brasó-Maristany, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona
Dr. Ángela Nieto, Instituto de Neurociencias UMH-CSIC, Alicante
Dr. Catherine Alix-Panabières, Université de Montpellier, France
INAUGURACIÓN OFICIAL /
OFFICIAL OPENING
EL VALOR DE OTROS BIOFLUIDOS COMO BIOPSIA LÍQUIDA /
THE VALUE OF OTHER BIOFLUIDS SUCH AS LIQUID BIOPSY
Dr. Cristina Saura, Vall d’Hebron Barcelona Hospital Campus
Dr. Fran Martinez-Ricarte, Vall d’Hebron Barcelona Hospital Campus
BIOPSIA LÍQUIDA EN TUMORES DEL TRACTO DIGESTIVO /
LIQUID BIOPSY IN
GASTROINTESTINAL TUMOURS
Dr. Rodrigo Toledo, Vall d’Hebron Instituto de Investigación (VHIR), Barcelona
Dr. Julie Earl, Hospital Universitario Ramón y Cajal, Madrid
MESA REDONDA SOBRE LA APLICACIÓN DE BIOPSIA LÍQUIDA PARA DETECCIÓN
PRECOZ /
PANEL DISCUSSION ON THE APPLICATION OF LIQUID BIOPSY FOR EARLY
DETECTION
Dr. Adam Januszewski, Medical Oncology Consultant, The Barts Thorax Centre, St. Bartholomew’s Hospital, London, UK
COMUNICACIONES ORALES SELECCIONADAS /
SELECTED ORAL
COMMUNICATIONS
MARCADORES EPIGENÉTICOS EN BIOPSIA LÍQUIDA /
EPIGENETIC MARKERS IN LIQUID BIOPSY
Dr. Ángel Díaz Lagares, Complexo Hospitalario Universitario de Santiago de Compostela
NUEVAS FRONTERAS PARA LA APLICACIÓN DE BIOPSIA LÍQUIDA EN CÁNCER
DE MAMA /
NEW FRONTIERS IN THE APPLICATION OF LIQUID BIOPSY IN BREAST
CANCER
Dr. Iñaki Comino-Méndez, Instituto de Investigación Biomédica de Málaga (IBIMA)
LA LLEGADA DE LA MULTIÓMICA GRACIAS A LA INTELIGENCIA ARTIFICIAL /
THE ARRIVAL OF MULTIOMICS THANKS TO ARTIFICIAL INTELLIGENCE
Dr. Vanja Miskovic, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Dr. Thomas Wieland, Foundation Medicine, Penzberg, Germany
MANEJO DE TUMORES GENITOURINARIOS A TRAVÉS DE BIOPSIA LÍQUIDA /
MANAGEMENT OF GENITOURINARY TUMORS THROUGH LIQUID BIOPSY
Dr. Carmen Jerónimo, Instituto Português de Oncologia do Porto (IPO-Porto)
Dr. Joaquín Mateo, Vall d’Hebron Instituto de Investigación (VHIR), Barcelona
MESA REDONDA: INTEGRANDO LA BIOPSIA LÍQUIDA EN LOS COMITÉS
DE TUMORES /
PANEL DISCUSSION ON INTEGRATING LIQUID BIOPSY INTO
MOLECULAR TUMOUR BOARDS
CLAUSURA Y ENTREGA DE PREMIOS DEL CONCURSO DE PÓSTERS /
CLOSING AND POSTER COMPETITION AWARDS CEREMONY
Frequently asked questions
Para más información puede dirigirse a la Secretaría Técnica: congresos@tacticsmd.net
Organized by:

Technical Secretary:
Copyright ©
Tactics MD. All rights reserved.